Primary Biliary Cholangitis Trial, Recruiting (NCT07598669)

Primary Biliary Cholangitis Trial, Recruiting NCT07598669 Sponsor: Medical University of Vienna Condition: Primary Biliary Cholangitis

Printed from Voxsanity (voxsanity.com.au) — NCT07598669 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Primary Biliary Cholangitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be over 18 years old.
You must have a confirmed diagnosis of primary biliary cholangitis (PBC), meaning at least two of the following three things apply to you: your liver enzyme levels (specifically alkaline phosphatase) have been higher than normal for at least 6 months; you have tested positive for certain specific antibodies (proteins in your blood) linked to PBC; or a liver tissue sample (biopsy) has shown changes typical of PBC.
You must be willing and able to sign a written consent form agreeing to take part in the registry.

Who may not be able to join:

Anyone who withdraws (takes back) their written consent to participate will no longer be eligible to remain in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +43 1 40400 47410

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07598669

Sponsor: Medical University of Vienna

Phase: Not Applicable

Status: Recruiting

Condition: Primary Biliary Cholangitis

Trial contact: +43 1 40400 47410

More information: https://clinicaltrials.gov/study/NCT07598669

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be over 18 years old.
You must have a confirmed diagnosis of primary biliary cholangitis (PBC), meaning at least two of the following three things apply to you: your liver enzyme levels (specifically alkaline phosphatase) have been higher than normal for at least 6 months; you have tested positive for certain specific antibodies (proteins in your blood) linked to PBC; or a liver tissue sample (biopsy) has shown changes typical of PBC.
You must be willing and able to sign a written consent form agreeing to take part in the registry.

Who may not be able to join:

Anyone who withdraws (takes back) their written consent to participate will no longer be eligible to remain in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medical University of Vienna

Registry

ClinicalTrials.gov

Start date

18 March 2026

Est. completion

1 December 2040

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Transplant-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov